$MOH

'Big Short' Investor Michael Burry Doubles Down on This Health Care Stock

“Big Short” investor Michael Burry increased his stake in Molina Healthcare (MOH), adding shares around $198 and saying the position is fully sized. The article notes Molina’s quarterly results beat expectations but sentiment has been pressured by rising medical expenses and issues in its Marketplace business, including weaker-than-expected enrollment. Jefferies analyst David Windley kept a Hold rating citing Marketplace concerns.

Original reporting
Published Aug 13, 2026, 3:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 7:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
'Big Short' Investor Michael Burry Doubles Down on This Health Care Stock — source image
Decision brief

The 30-second read

$MOHNeutralLow
01

Why it matters

Burry’s reported doubling down is a positioning signal that may attract contrarian flows, but it is not accompanied by new MOH disclosures (guidance, filings, regulatory decisions) that would materially reset valuation or risk.

02

Market read

Traders get a contrarian sentiment datapoint on MOH, but the article lacks new operational or regulatory information to justify a high-conviction trade catalyst.

03

What to watch

The article does not provide new MOH enrollment, medical expense ratio, or guidance numbers; traders may be over-weighting the political catalyst versus the operational drivers (cost trend, attrition, and Marketplace performance).

Relevance 4/10Novelty 3/10Timing: today’s read-through on MOH positioning ahead of the next election cycle

Background

The piece frames MOH as facing near-term pressure from rising medical expenses and Marketplace enrollment/attrition concerns, even after quarterly results above expectations.

Company-level read

Ticker impact

$MOHNeutralMedium confidence
Context

Michael Burry increased his stake in Molina Healthcare, adding shares around $198 and calling the position fully sized despite recent medical-expense and Marketplace pressure.

Expected impact

Near-term impact likely limited, with any move driven more by broader health-insurer sentiment than by new MOH-specific disclosures.

Evidence & confidence

The only concrete new fact is Burry’s reported buy/add and his stated rationale; the rest references prior results/analyst concerns without fresh MOH guidance, filings, or regulatory actions.

Market effects

Could modestly influence sentiment toward managed care/Medicaid-Medicare insurers if traders treat Burry’s move as a contrarian endorsement amid medical-cost and Marketplace enrollment worries.

Primarily US-focused given the US health insurance and Marketplace context.

Limited, as the catalyst is investor positioning and US election-cycle narrative rather than global policy or cross-border fundamentals.

Counterpoint

Burry’s add may reflect portfolio rebalancing or a long-horizon thesis, not a near-term inflection in MOH’s medical-cost trend or Marketplace retention metrics.

Key entities

  • Molina Healthcare

    US managed care insurer discussed as the recipient of Michael Burry’s increased stake.

  • Michael Burry

    Reported to have added shares around $198 and described the position as fully sized.

  • David Windley

    Jefferies analyst cited for a Hold rating and concerns about Marketplace operations.

Related articles

$CNCMedAI 8/10

CNC, UNH, CVS, HUM Stocks Slip After-Hours — Trump Administration Reportedly Seeks To Scrap Subsidies On Certain Medicare Plans

Shares of Centene (CNC), UnitedHealth (UNH), CVS (CVS), and Humana (HUM) fell after-hours Tuesday after a report that the Trump administration plans to end a $3.6B federal subsidy for Medicare Part D plans post-2026. The subsidy helps keep premiums low for 25M enrollees. The loss of support could pressure margins and enrollment for insurers offering stand-alone Part D plans, though some beneficiaries may shift to Medicare Advantage plans.

$MOHMedAI 8/10

Molina Healthcare Q2 Earnings Call Highlights

Molina Healthcare (MOH) discussed Q2 results on its earnings call. Medicaid MCR was 92.4% in first half, expected to rise to 93.3% in second half. Medicare MCR was 90.7% and full-year Medicare MCR guidance was cut to 92.2%, with 2026 EPS contribution of $0.25. Marketplace MCR pressure led to raised 2026 guidance to 90% and a shift to a $0.75 per share loss. 2027 premium outlook is about $46.5B.

$MOHMedAI 8/10

Why is Molina Healthcare stock sliding today? By Investing.com

Molina Healthcare (MOH) fell about 9.2% in pre-open trading after reporting Q2 2026 results. Adjusted EPS was $1.51 vs. ~$1.39–$1.40 expected, and revenue was ~$10.87B. Full-year 2026 revenue guidance was ~$42B vs. ~$44.28B consensus, with Medicaid margin “trough year” comments, enrollment pressure, and Florida CMS contract startup costs cited.

$MOHMedAI 8/10

Molina raises full year 2026 guidance after Q2 results

Molina Healthcare reported Q2 2026 adjusted EPS of $1.51, above the $1.39 consensus. Revenue fell to $10.874B from $11.427B a year earlier, while GAAP net income declined to $60M. The company raised full-year 2026 adjusted guidance to at least $5.25 per diluted share and GAAP to at least $2.15. Analysts at RBC, Wells Fargo, and TD Cowen raised price targets for MOH.

$MOHMedAI 8/10

Molina Healthcare stock falls as first-half EPS covers 73.5% of 2026 floor

Molina Healthcare (NYSE:MOH) shares fell 9.4% to $200.85 after hours after its first-half adjusted EPS covered 73.5% of its new 2026 EPS floor. Adjusted EPS was $3.86 in the first half versus a $5.25 floor, leaving a $1.39 gap. Premium revenue fell 6% and medical costs rose, with guidance changes tied to Medicaid, Medicare, and Marketplace.